David Harpole, MD / Nicolas Girard, MD, PhD - Trials and Tribulations: Examining the Data for Perioperative Immunotherapeutic Approaches in Resectable NSCLC
CME in Minutes: Education in Oncology & Hematology11/20/24 • 31 min
Please visit answersincme.com/860/94256783-replay2 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in non–small-cell lung cancer (NSCLC) discuss the clinical significance of the latest efficacy and safety data for perioperative immunotherapeutic regimens for resectable NSCLC. Upon completion of this activity, participants should be better able to: Review the significance of the latest clinical data of perioperative immunotherapeutic approaches in patients with resectable NSCLC (rNSCLC); and Outline strategies for the optimization of long-term management of rNSCLC with perioperative immunotherapeutic regimens.
11/20/24 • 31 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/cme-in-minutes-education-in-oncology-and-hematology-449630/david-harpole-md-nicolas-girard-md-phd-trials-and-tribulations-examini-78634435"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to david harpole, md / nicolas girard, md, phd - trials and tribulations: examining the data for perioperative immunotherapeutic approaches in resectable nsclc on goodpods" style="width: 225px" /> </a>
Copy